17 Recruiting Trials

Clinical Trials
for Alzheimer's in Maryland

17 clinical trials for Alzheimer's are currently recruiting participants at study sites in Maryland. Study-related care is provided at no cost.

17
Recruiting trials
16
Study sites
7
Cities
6
Industry-sponsored
6
Phase 2
3
Phase 3

Alzheimer's clinical trials in Maryland: what to expect

Alzheimer's trials now span the whole course of the disease. Prevention studies enroll people with normal memory who have early signs of amyloid in the brain; treatment studies enroll people with mild cognitive impairment or early Alzheimer's and test the next generation of antibodies, tau-targeting drugs and combinations; and symptom studies address agitation, sleep and depression in later stages. Alongside drugs there are trials of exercise, cognitive training, blood tests for diagnosis and support programs for care partners.

In Maryland, recruiting alzheimer's studies are concentrated in Baltimore, Gaithersburg, Bethesda and Clinton, with sites in 3 other cities. 6 of the 17 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who Alzheimer's trials usually look for

Most drug trials enroll ages 50 to 85 and define a stage with a memory test score range, then confirm Alzheimer's with an amyloid PET scan, a spinal fluid test or, increasingly, a blood test, all done by the study. Nearly every trial requires a study partner: someone who knows you well, attends visits and answers questions about daily life. Common exclusions are another cause of memory loss, a recent stroke and, for antibody trials, some blood thinners or MRI findings. Prevention trials enroll people with no symptoms at all.

What taking part involves

Screening is longer than for most conditions, often several visits over a few weeks with memory testing, an MRI and an amyloid test. Antibody trials then involve an infusion or injection every two to four weeks, regular safety MRIs and visits for eighteen months to four years, with an extension in which everyone receives the drug. Lifestyle trials involve classes or coaching for six to twenty-four months. All study care is free and travel is usually reimbursed for you and your partner.

Questions worth asking the study team

Whether you will be told your amyloid or genetic results; what the MRI safety monitoring involves; how much time the study partner must give; whether there is an extension after the placebo period; and what happens if memory worsens during the study.

Showing 17 of 17 recruiting Alzheimer's trials in Maryland

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
PHASE2 Baltimore, Maryland NCT07721467
This trial is looking for older adults aged 65 and over who have mild cognitive impairment or early-stage Alzheimer's disease, as well as healthy older adults. Participants will engage in brain training exercises and may take psilocybin, a compound found in certain mushrooms, to see how it can improve brain function.
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2 Chandler, Arizona +4 sites NCT06159673
This trial is looking for adults aged 55 to 95 who have Alzheimer's disease psychosis. Participants will receive either ACP-204 or a placebo for six weeks, with follow-up visits to check on their health afterwards.
Recruiting
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
N/A Baltimore, Maryland NCT06058234
This trial is looking for Medicare patients diagnosed with mild Alzheimer's disease or mild cognitive impairment due to Alzheimer's disease. Participants will help collect data to support treatments for these conditions.
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
PHASE3 Chandler, Arizona +4 sites NCT06937229
This trial is looking for people with agitation related to Alzheimer's Disease who have completed earlier studies. Participants will take a combination of two specific medications to see how well they work over time and if they are safe.
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3 Scottsdale, Arizona +4 sites NCT07011732
This trial is looking for adults with Alzheimer's disease who experience agitation. Participants will take the study medication and have regular visits to assess their condition.
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2 Phoenix, Arizona +4 sites NCT06847321
This trial is looking for people with mild to moderate Alzheimer's who also have a specific infection. Participants will take a daily capsule and attend study visits over 64 weeks.
Recruiting
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2 Maitland, Florida +4 sites NCT05543681
This trial is looking for people with Alzheimer's who experience agitation. Participants will take a THC-based medication twice a day and will be monitored for its effects.
Recruiting
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
EARLY_PHASE1 Baltimore, Maryland NCT04123314
This trial is looking for people with Mild Cognitive Impairment or early Alzheimer's Disease who are experiencing depression. Participants will take the drug psilocybin in a supportive environment to see if it helps improve their mood and quality of life.
Recruiting
Music Therapy for Patients With Alzheimer's Disease
NA Baltimore, Maryland NCT05151562
This trial is looking for adults with mild cognitive impairment or early Alzheimer's disease. Participants will take part in virtual music therapy sessions for 8 weeks to see if it helps improve memory, mood, and thinking skills.
Recruiting
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
NA Baltimore, Maryland NCT05795634
This trial is looking for older adults with mild cognitive impairment who can return for a follow-up visit in two years. Participants will provide samples, take tests of memory and thinking, and answer questions about their daily functioning.
Recruiting
Vestibular Therapy in Alzheimer's Disease
NA Baltimore, Maryland NCT03799991
This trial is looking for older adults with Alzheimer's disease who have balance problems. Participants will take part in vestibular therapy sessions and exercises over 8 weeks to see if it helps reduce falls.
Recruiting
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
PHASE2 Baltimore, Maryland NCT05282550
This trial is looking for people with mild cognitive impairment who have trouble sleeping. Participants will take trazodone to see if it helps improve their sleep and memory.
Recruiting
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
PHASE1 Bethesda, Maryland NCT07169630
This trial is looking for volunteers aged 50 and older with Alzheimer’s Disease or Mild Cognitive Impairment, as well as healthy individuals. Participants will undergo medical imaging scans of the brain over several clinic visits.
Recruiting
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
PHASE1 Bethesda, Maryland NCT04396873
This trial is looking for adults with certain brain diseases like Alzheimer's or healthy volunteers. Participants will undergo medical tests and scans to study inflammation in the brain.
Recruiting
Crownlands Observing Progression With Neurons Study
N/A Germantown, Maryland NCT07611396
This trial is looking for adults aged 55 and older with mild cognitive impairment or Alzheimer’s disease. Participants will undergo assessments and provide samples at clinical sites.
Recruiting
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
PHASE2 Baltimore, Maryland NCT04601038
This trial is looking for people with mild cognitive impairment or those at risk for Alzheimer’s disease. Participants will take either a study drug or a placebo for 10 weeks and will complete some memory and thinking tests.
Recruiting
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
NA Baltimore, Maryland NCT06930560
This trial is looking for older adults with Alzheimer’s Disease or related dementias who have hearing loss. Participants will receive a special hearing care program to help with communication and related symptoms.
Recruiting

Where the Alzheimer's studies are in Maryland

  • Johns Hopkins School of Medicine, Baltimore3 trials
  • National Institutes of Health Clinical Center, Bethesda2 trials
  • CBH Health, Gaithersburg1 trial
  • CBH Health LLC, dba CenExcel Gaithersburg, Gaithersburg1 trial
  • Capital Neurology, Germantown1 trial
  • Centers for Medicare and Medicaid Services, Baltimore1 trial

Counts are recruiting studies listing at least one site in Maryland, from ClinicalTrials.gov, refreshed every two days.

Alzheimer's clinical trials in Maryland: common questions

How many Alzheimer's clinical trials are recruiting in Maryland?
TrialFinder currently lists 17 recruiting Alzheimer's clinical trials with study sites in Maryland. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Alzheimer's clinical trials located in Maryland?
Study sites for the Alzheimer's trials listed on this page include Baltimore, Bethesda, Germantown. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Alzheimer's clinical trial in Maryland?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Alzheimer's trials in Maryland also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Alzheimer's clinical trial in Maryland?
Each study sets its own criteria based on age, Alzheimer's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need an Alzheimer's diagnosis to join a trial?
No. Prevention trials enroll people with normal memory and test them for early amyloid, and many treatment trials accept people with memory concerns who have not been formally diagnosed, then confirm the diagnosis as part of screening.
What is a study partner?
A family member or close friend who attends visits with you and answers questions about memory and daily activities. Nearly every Alzheimer's trial requires one, and their time is usually reimbursed too.
Will I learn my amyloid or APOE results?
Many trials now disclose amyloid status, since it decides eligibility, and explain what it means. Genetic results are disclosed in some trials and not others; ask before you consent.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Alzheimer's trials near you in Maryland.

Get Matched — Free
No insurance required

Alzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.

All Alzheimer's trials →